RevMed
Home/Specialty/Gastroenterology & Urology/Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

651 Results
Results Per Page
  • 50
  • 100
  • 250
Catalog #
Qty
Starting At
Name
Company Name
Description
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 9 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 35X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 4.5 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 35X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 25.6 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 12.8 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 20.5 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 2 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 10.2 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 5.1 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 9.3 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 4.6 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 26 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 13 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 20.8 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 2 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (I GALLON) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 10.4 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 5.2 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.78 LITER (1 GALLON) IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 18.8 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 2 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 9.4 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE USP 4.7 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 36.83X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 31.3 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 15.6 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 26.4 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 8 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 13.2 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 8 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 25 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 2 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 12.5 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 6.3 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 11.3 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 5.7 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
CALCIUM CHLORIDE USP 2.8 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.25 mEq/L INCREASE WHEN ADDED TO 3.43 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 31.7 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/LITER INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 15.9 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/LITER INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 26.8 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/LITER INCREASE WHEN ADDED TO 8 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 13.4 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/LITER INCREASE WHEN ADDED TO 8 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 25.4 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 2 mEq/LITER INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 12.7 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/LITER INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 6.3 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/LITER INCREASE WHEN ADDED TO 3.78 LITERS (1 GALLON) IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 23 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 2 mEq/LITER INCREASE WHEN ADDED TO 3.43 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 11.5 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/LITER INCREASE WHEN ADDED TO 3.43 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Hemo-Dial
EDLAW PHARMACEUTICALS, INC.
POTASSIUM CHLORIDE 5.8 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 0.5 mEq/LITER INCREASE WHEN ADDED TO 3.43 LITERS IN A 45X PROPORTIONING SYSTEM
0
-
Premixed Dialysate for Hemodiafiltration
Nikkiso Belgium BVBA
Premixed Dialysate for Hemodiafiltration is indicated for acute dialysis modalities that employ hemodiafiltration, such as continuous arteriovenous hemodiafiltration (CAVHD) and Continuous Venous-Venous Hemodiafiltration (CVVHD), when treatment of actue renal failure patients with hypervolemia and uremia requires high solute clearance.
0
-
ACCUSOL Dialysis Solution for CRRT
Nikkiso Belgium BVBA
Accusol 30 2K+ 0Ca++ Solution is indicated for use as dialysis solution in Continuous Renal Replacement Therapy.
0
-
ACCUSOL Dialysis Solution for CRRT
Nikkiso Belgium BVBA
Accusol 30 2K+ Solution is indicated for use as dialysis solutions in Continuous Renal Replacement Therapy.
0
-
ACCUSOL Dialysis Solution for CRRT
Nikkiso Belgium BVBA
Accusol 35 0K+ 0DEX Solution is indicated for use as dialysis solution in Continuous Renal Replacement Therapy.
0
-
ACCUSOL Dialysis Solution for CRRT
Nikkiso Belgium BVBA
Accusol 35 2K+ Solution is indicated for use as dialysis solution in Continuous Renal Replacement Therapy.
0
-
ACCUSOL Dialysis Solution for CRRT
Nikkiso Belgium BVBA
Accusol 35 4K+ Solution is indicated for use as a dialysis solution in Continuous Renal Replacement Therapy.
0
-
PrismaSATE
BAXTER INTERNATIONAL INC.
The product is a sterile dialysis solution intended for treatment of acute kidney disease (renal failure) using Continuous Renal Replacement Therapies, such as continuous hemodialysis and hemodiafiltration aimed at normalizing the composition of the blood. The product may also be used in case of drug poisoning with dialyzable or filterable substances.
0
-
PrismaSATE
BAXTER INTERNATIONAL INC.
The product is a sterile dialysis solution intended for treatment of acute kidney disease (renal failure) using Continuous Renal Replacement Therapies, such as continuous hemodialysis and hemodiafiltration aimed at normalizing the composition of the blood. The product may also be used in case of drug poisoning with dialyzable or filterable substances.
0
-
PRISMASATE
BAXTER INTERNATIONAL INC.
The product is a sterile dialysis solution intended for treatment of acute kidney disease (renal failure) using Continuous Renal Replacement Therapies, such as continuous hemodialysis and hemodiafiltration aimed at normalizing the composition of the blood. The product may also be used in case of drug poisoning with dialyzable or filterable substances.
0
-
PRISMASATE
BAXTER INTERNATIONAL INC.
The product is a sterile dialysis solution intended for treatment of acute kidney disease (renal failure) using Continuous Renal Replacement Therapies, such as continuous hemodialysis and hemodiafiltration aimed at normalizing the composition of the blood. The product may also be used in case of drug poisoning with dialyzable or filterable substances.
0
-
BiCart
Baxter Healthcare SA
Sodium Bicarbonate for Hemodialysis
0
-
PrismaSATE
BAXTER INTERNATIONAL INC.
The product is a sterile dialysis solution intended for treatment of acute kidney disease (renal failure) using Continuous Renal Replacement Therapies, such as continuous hemodialysis and hemodiafiltration aimed at normalizing the composition of the blood. The product may also be used in case of drug poisoning with dialyzable or filterable substances.
0
-
PrismaSATE
BAXTER INTERNATIONAL INC.
The product is a sterile dialysis solution intended for treatment of acute kidney disease (renal failure) using Continuous Renal Replacement Therapies, such as continuous hemodialysis and hemodiafiltration aimed at normalizing the composition of the blood. The product may also be used in case of drug poisoning with dialyzable or filterable substances.
  1. 1
  2. …
  3. 5
  4. 6
  5. 7
  6. …
  7. 14
PreviousNext